Cargando…
COMMD4 is a novel prognostic biomarker and relates to potential drug resistance mechanism in glioma
Background: Glioma as the most frequently discovered tumor affecting the brain shows significant morbidity and fatality rates with unfavorable prognosis. There is an urgent need to find novel therapeutic targets to overcome the low chemotherapeutic efficacy of glioma. This research examined whether...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562965/ https://www.ncbi.nlm.nih.gov/pubmed/36249824 http://dx.doi.org/10.3389/fphar.2022.974107 |